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Background: Chronic systemic inflammation accelerates early vascular ageing. Atopic 2 
sensitization and allergic diseases may involve increased inflammatory activity. This study 3 
aimed to assess whether atopic sensitization and allergic diseases were associated with altered 4 
vascular biomarkers in Norwegian adolescents.  5 
Methods: Distensibility coefficient of the common carotid arteries, carotid intima-media 6 
thickness and atopic sensitization (serum total and specific IgEs) were assessed in 95 7 
Norwegian adolescents, who participated in the RHINESSA generation study. Symptoms of 8 
allergic disease were assessed by an interviewer-led questionnaire. 9 
Results: Atopic sensitization was found in 33 (34.7%) of the adolescents. Symptomatic 10 
allergic disease was found in 11 (33.3%) of those with atopic sensitization. Distensibility 11 
coefficient of the common carotid arteries appeared to be lower in participants with atopic 12 





p>0.05), while carotid intima-media thickness did not differ between these groups 14 
(0.50±0.04mm versus 0.50±0.04mm; p>0.05). Crude, as well as age- and sex-adjusted 15 
multiple regression, revealed no significant association, neither of atopic sensitization nor of 16 
allergic disease, with distensibility coefficient of the common carotid arteries and carotid 17 
intima-media thickness. 18 
Conclusions: Our results do not support the assumption of an adverse impact of atopic 19 
sensitization and/or allergic disease on distensibility coefficient of the common carotid 20 
arteries and carotid intima-media thickness in Norwegian adolescents. Further research is 21 
necessary to study whether the clinical severity of allergic diseases might be more important 22 
than the status of allergic disease or atopic sensitization. 23 





Evidence is growing, that inflammatory processes play an important role in atherogenesis, 26 
promoting the risk of cardiovascular diseases (1). Possible pathophysiological links between 27 
inflammation and vascular damage were previously described (2-8). One of the most 28 
investigated mechanisms is the oxidative modification of LDL, which leads to foam cell 29 
formation and development of lesions in the vascular wall (2, 3). Wang et al. observed a 30 
stimulated arterial cell apoptosis and cytokine expression in humans and mice by elevated 31 
serum IgE levels (4). This might be preceded by decreased serum-levels of low-affinity IgE 32 
receptor-positive B cells, as observed after coronary artery bypass graft surgery (5). A 33 
possible link between chronic inflammatory activity caused by atopic sensitization and 34 
atherosclerosis might be an elevated activity of mast cells, which leads to multiple effects in 35 
the vascular wall, promoting development and vulnerability of atherosclerotic lesions (6). The 36 
influence of childhood exposure to several pro-inflammatory risk factors on vascular health in 37 
adult life has previously been shown, as well as the relevance of childhood exposure to 38 
cardiovascular risk factors for the later development of atherosclerosis (9-13). Repeated 39 
bacterial or viral infections, obesity and diabetes mellitus are strong promoters of increased 40 
carotid intima-media thickness (cIMT) in children by means of chronically elevated 41 
inflammatory activity (14-16). So far, a possible association of chronic systemic inflammation 42 
related to atopic sensitization with cIMT and other biomarkers of early vascular ageing has 43 
been analyzed mainly in adult populations (17, 18). However, a few studies suggested that 44 
allergic diseases might contribute to early vascular ageing already in early childhood (19, 20).  45 
Atopic sensitization, independent of its clinical penetrance, involves chronic systemic 46 
hyperinflammation. Hence, we hypothesized that atopic sensitization might contribute to early 47 
vascular ageing in young people. The primary aim of this study was to investigate a possible 48 




distensibility coefficient (DC) of the common carotid arteries and cIMT, which are indicators 50 
of early vascular ageing. Our second aim was to investigate whether the clinical manifestation 51 
of atopic sensitization might be associated with these parameters. Hence, we also analyzed the 52 
association of allergic disease with DC and cIMT.   53 
 54 
Methods: 55 
Study population 56 
All Norwegian offspring aged 10 to 18 years of ECRHS Bergen participants were invited to 57 
participate in the prospective RHINESSA generation study (Respiratory Health In Northern 58 
Europe, Spain and Australia, see www.rhinessa.net, Figure 1). Of the 285 offspring 125 had 59 
parental consent for clinical investigation and were screened for eligibility. Exclusion criteria 60 
were a recent operation, an acute infection, diabetes mellitus or other chronic inflammatory 61 
diseases unrelated to atopy, severe heart disease or pregnancy. Overall, we excluded two 62 
candidates because of diabetes mellitus type 1. Of the remaining 123 participants, 21 had no 63 
test of immunological total or specific IgE, because they had not agreed for blood analysis. 64 
Furthermore, seven participants’ ultrasound images did not meet the predefined quality 65 
criteria (see supplementary materials 2 for further details). Therefore, 95 participants were 66 
available for main analysis (Figure 1). 67 
Data analysis was performed in accordance with the Declaration of Helsinki and approved by 68 
the Regional committee for Medical and Health Research Ethics, Western Region (REC West 69 
2012/1077). Written informed consent was retrieved prior to participation (from parents if the 70 
offspring was below 16 years of age, from the offspring themselves if 16 years or older). 71 
 72 




*n=2 with type 1 diabetes mellitus. Further predefined exclusion criteria were recent 74 
operation, an acute infection, diabetes mellitus type 2, any chronic inflammatory diseases unrelated 75 
to atopy, severe heart disease and pregnancy; 
&
No participant´s consent for blood tests. 76 
 77 
Questionnaires 78 
Extensive information on respiratory health, allergic diseases, general health and 79 
environmental exposures were assessed by a web-based questionnaire, covering all possible 80 
covariates for the analysis: parents’ atopy status, physical activity, frequent exposure to 81 
smoking (either active smoking or exposure to regular parental smoking at home), modality of 82 
birth (caesarean section versus natural birth) and preterm birth. 83 
An interviewer-led questionnaire before clinical examination assessed respiratory symptoms 84 
during the last months and specifically during the last three days and current medication. 85 
Participants were asked to bring any regular or emergency medication to the study centers. 86 
Clinical examinations 87 
Based on interview data on hours since having smoked or consumed food and drinks, 88 
medication use, and current infections, no participants were excluded from specific 89 
examinations. Afterwards, we conducted spirometry, FeNO analysis, analysis of total and 90 
specific IgE and anthropometric measures (see supplementary materials 1 for detailed 91 
information). 92 
Main predictors: Atopic sensitization and allergic disease 93 
Atopic sensitization was defined as a positive total or specific IgE towards inhalant allergens 94 
(house dust mite, cat, Timothy (grass), birch, and Cladosporium). Allergic disease was 95 




atopic eczema, food allergy, allergic bronchial asthma or frequent use of doctor-prescribed 97 
antihistaminic medication (see supplementary materials 1 for further details).   98 
Ultrasonographic examination and main outcomes: DC and cIMT 99 
ECG derived heart rate as well as systolic and diastolic blood pressure were obtained 100 
simultaneously during the ultrasonographic assessment of DC and cIMT. Blood pressure was 101 
measured on the left upper arm with an OMRON 705 IT-IS Automatic-IS device just before 102 
the examination was started and after ten minutes of rest in a sitting position. The appropriate 103 
cuff size was determined by measuring the upper arm circumference. 104 
The procedure of DC and cIMT measurement was performed by two trained field workers, 105 
using an ultrasound instrument (UF-870, Fukuda Denshi Co. Ltd., Tokyo, Japan) with a LA38 106 
5-16 MHz linear probe. Temporal resolution was 10.47 ms per frame. Data assessment was 107 
conducted using an automated wall-detection software, as previously described and in 108 
accordance with current recommendations to ensure acceptable data quality (see 109 
supplementary materials 2 for further details; (21, 22)). In the pre-study training examinations 110 
intraobserver variability  was 7.2 and 7.9%, respectively, and, thus, similar to typical values 111 
(23). Interobserver variability was 10.7% and, thus, slightly higher than previously reported 112 
values (23). Near- and far-wall cIMT as well as end diastolic and peak systolic outer lumen 113 
diameter were obtained from four examination planes (bilateral common carotid artery 114 
horizontal plane and ear-to-ear plane, respectively) (21). Afterwards, a mean DC [10
-3
/kPa] 115 
and mean cIMT [mm] were calculated for each participant and used for further statistical 116 
analysis (see supplementary materials 2 for further details). Validity, reliability and clinical 117 
predictive value of DC and cIMT in children and adolescents have been shown previously 118 
(24-27). 119 




Data analysis was performed using SPSS version 25.0 for Windows (SPSS Inc., Chicago, 121 
Illinois, USA) and R version 3.5.0 for Windows (R Foundation for Statistical Computing, 122 
Vienna, Austria). Descriptive analysis included means, standard deviations (SD), minimum 123 
and maximum values. The level of significance was set at p ≤ 0.05; estimated effects were 124 
reported with 95% confidence intervals (95% CI). 125 
Unadjusted (crude) linear regression models, as well as age- and sex-adjusted multiple 126 
regression models were applied to analyze associations of DC and cIMT with atopic 127 
sensitization and allergic diseases. 128 
Complete data were available for 95 (81.1%) of 117 participants. In the remaining 22 cases 129 
parental or participants´ consent for IgE analyses was not given. We used multiple imputation 130 
by chained equations using the “mice” package in R (version 3.0.3) to impute the missing 131 
data (28, 29). Specifically, we imputed 300 datasets with 10 iterations each. Convergence and 132 
distribution of imputed values were assessed graphically. We applied predictive mean 133 
matching for imputation of continuous variables, logistic regression for binary variables and 134 
ordered logistic regression for ordered categorical variables (30). The results from the 135 
regression models based on the imputed datasets were pooled using Barnard-Rubin adjusted 136 
degrees of freedom for small samples (31).  137 
We repeated all statistical analyses with height-related standard deviation scores (SDS) of DC 138 
and cIMT, because height seems to be a strong determinant for vascular wall properties in 139 
childhood and adolescence (25). Sensitivity analyses were performed including factors, which 140 
are more or less controversially discussed in literature as possibly being relevant for early 141 
vascular ageing and also the risk of atopic sensitization. These factors are current exposure to 142 
smoking (passive and active) (32, 33), physical activity (34), preterm birth (35) and delivery 143 
by caesarean section (36). None of these additional analyses resulted in significantly different 144 






Basic characteristics of the study population 148 
General empiric and vascular characteristic were comparable in participants with and without 149 
atopic sensitization (Table 1). Atopic sensitization was found in 33 (34.7%) of all participants 150 
with available blood samples. Of these participants, allergic disease was found in 11 (33.3%) 151 
individuals. Nine of them took antiallergic medication on a regular basis at the time of 152 
examination. Mean DC was 46.99±8.07*10
-3
/kPa in the group with atopic sensitization and 153 
51.50±11.46*10
-3
/kPa in the group without atopic sensitization. Mean cIMT was 154 
0.50±0.04mm in both groups.  155 
  Mean (standard deviation; min/max) / n (%) 
  
Atopic sensitization   (n=33; 
34.7%) 





Empiric characteristics    
Age [years] 15.3 (±1.7; 12.4/18.5) 15.1 (±2.7; 9.8/18.7) ns 
Female 16 (48.5%) 32 (51.6%) - 
Height [cm] 169 (±9.2; 148/189) 166 (±13.7; 130/188) ns 
BMI [kg/m
2
] 21.4 (±3.3; 16.0/28.7) 21.0 (±4.1; 14.7/38.2) ns 
BMI-SDS
&







/kPa] 46.99 (±8.07; 28.79/63.97) 51.50 (±11.46; 29.30/95.83) ns 




cIMT [mm] 0.50 (±0.04; 0.42/0.59) 0.50 (±0.04; 0.42/0.62) ns 
cIMT-SDS* 2.30 (±0.88; 0.40/4.19) 2.31 (±0.85; 0.69/4.53) ns 
BPsys [mmHg] 108 (±8.1; 92/123) 107 (±8.4; 91/128) ns 
BPdia [mmHg] 58 (±4.7; 49/73) 62 (±6.5; 52/90) 0.01 
Heart rate [bpm] 68 (±19.2; 48/143) 69 (±18.8; 45/170) ns 
Table 1: Population characteristics.  156 
BMI = Body mass index; BMI-SDS = Standard deviation score of BMI; DC = Distensibility 157 
coefficient of the common carotid arteries; DC-SDS = Standard deviation score of DC; cIMT 158 
= Carotid intima-media thickness; cIMT-SDS = Standard deviation score of cIMT; BPsys = 159 
Blood pressure, systolic; BPdia = Blood pressure, diastolic. 
#
T-test derived differences 160 
between subpopulations with and without atopic sensitization were considered significant, if 161 
two-tailed p ≤ 0.05 (ns = p > 0.05). 
&
Norwegian reference population (37). *Mainly 162 
European reference population (25). 163 
 164 
Association of atopic sensitization with biomarkers of early vascular ageing 165 
Neither crude comparison of DC and cIMT, nor the age- and sex-adjusted multivariate 166 
regression model, indicated a significant association of atopic sensitization with these 167 
parameters (Table 2). However, DC tended to be lower in participants with atopic 168 










 DC crude -3.10 -8.80 2.60 0.28 




  cIMT crude 0.004 -0.01 0.02 0.66 
  cIMT adjusted* 0.004 -0.01 0.02 0.67 
Allergic disease
#
 DC crude -1.94 -10.42 6.53 0.64 
  DC adjusted* -1.01 -8.89 6.87 0.80 
  cIMT crude 0.009 -0.02 0.04 0.54 
  cIMT adjusted* 0.008 -0.02 0.04 0.60 
Table 2: Multiple linear regression analysis of associations of atopic sensitization and 171 
allergic disease with DC and cIMT.  172 
&
Atopic sensitization = any positive total or specific IgE in the serological analyses 173 
(dermatophagoides, cat, birch, timothy grass, cladosporium); 
#
Allergic disease = atopic 174 
sensitization plus two of the following clinical criteria: allergic rhinitis, atopic eczema, food 175 
allergy, allergic bronchial asthma or frequent use of doctor-prescribed antihistaminic 176 
medication; *Models adjusted for age and sex. DC = Distensibility coefficient of the common 177 
carotid arteries; cIMT = Carotid intima-media thickness; β = Estimated effect; CI = 178 
Confidence interval; level of significance set at p ≤ 0.05. 179 
 180 
Association of allergic disease with biomarkers of early vascular ageing 181 
Neither crude comparison of DC and cIMT, nor the age- and sex-adjusted multivariate 182 
regression model, indicated a significant association of allergic disease with DC and cIMT 183 
(Table 2). 184 
 185 
Discussion: 186 
Mean DC tended to be lower in participants with atopic sensitization than in those without. 187 
However, atopic sensitization revealed no significant association with DC and cIMT in this 188 
study population of Norwegian adolescents. Further, no significant associations of clinically 189 




In 2015, Evelein et al. found an increased cIMT in five-year old children with several clinical 191 
forms of allergies but no changes in arterial distensibility and elasticity (20). They concluded 192 
that allergies are associated with arterial changes in young children. However, our data do not 193 
support their cIMT findings. Possibly, age as well as timing and severity of clinical 194 
manifestations of atopy might play a role. Yet, the tendency towards a lower DC in our 195 
participants with atopic sensitization might be a very early sign for a chronic subclinical 196 
impact of atopic sensitization on vascular ageing. Helpful markers of the severity of systemic 197 
inflammatory activity (i. e. oxLDL, high-sensitivity C-reactive protein, soluble interleukin-2 198 
receptor, eosinophil cationic protein) were not available in both studies. However, we 199 
analyzed total and specific IgE, which are valid markers for qualitative assessment of atopic 200 
sensitization but do not give information about the severity of systemic inflammatory activity 201 
(38). We assume that the inflammatory activity in our study population might have been 202 
somewhat heterogeneous, which would explain the lack of association of atopic status and 203 
allergic disease with DC and cIMT. Whether the strength of such an association might depend 204 
on the severity of systemic inflammatory activity needs to be investigated in larger 205 
prospective studies including more information about current and cumulative lifetime 206 
systemic inflammatory activity. 207 
Another study found an adverse influence of repeated episodes of common childhood 208 
infectious diseases on cIMT (15). This has also been suspected by Liuba et al. in 2005 (9). 209 
Their multiple hit theory states that repeated episodes of acute infections might enhance 210 
oxidized modification of LDL, which plays an important role in the development of 211 
atherosclerosis by fostering foam cell accumulation and subsequent thickening of the vascular 212 
wall (39, 40). This association of inflammation and formation of atherogenic oxidized LDL 213 
(oxLDL) has been described in autoimmune disorders as well and a comparable 214 




triggered mast cell activation and an acute-phase reaction, both leading to increased oxidative 216 
stress (2, 18, 41). Activated mast cells degranulate cytokines, leukotrienes, prostaglandins and 217 
histamine, leading to endothelial activation and facilitated intracellular penetration of LDL 218 
(41). Endothelial oxidative modification of LDL might be enhanced in children with allergic 219 
diseases, due to increased oxidative stress and decreased antioxidative capacity (2, 42). 220 
Furthermore, several authors suggested that IgE-triggered mast cell activation during acute 221 
allergic reactions might lead to facilitated presentation of LDL to macrophages subsequently 222 
enhancing formation of foam cells (43, 44). It was also suggested, that atherogenic complexes 223 
of CRP and oxLDL with or without β2-glycoprotein-I might be present during acute phase 224 
reactions (2, 3, 45, 46). Accordingly, the severity of clinical penetrance of atopic sensitization 225 
in terms of cumulative lifetime load of number and severity of allergic bouts might be a key 226 
factor to produce a relevant atopy-associated effect on vascular ageing. The results of our 227 
analyses on participants with allergic diseases do not support this hypothesis. However, we 228 
did not have information about the severity of past clinical allergic episodes in our 229 
participants and the lifetime load of antiallergic treatment. Yet, clarification of this question 230 
might be of importance for clinicians, as they would be encouraged to control allergic 231 
diseases very carefully in order to avoid adverse effects on long-term vascular health in 232 
affected children and adolescents. Future studies should therefore obtain detailed information 233 
about the number and severity of acute clinical exacerbations of allergic diseases of their 234 
participants in the past and address this question. Finally, it would be intriguing to compare 235 
the levels of oxLDL during chronic and acute hyperinflammatory activity in atopic children 236 
and adolescents and investigate their association with accelerated arterial stiffening and 237 
increased intima-media thickness. 238 




The standardized, high-quality measurements of DC and cIMT in a cohort of adolescents was 240 
a main strength of our study. Although early structural changes due to chronic systemic 241 
inflammation have been reported in children and adolescents (15, 20, 47), one should be 242 
aware, that the assessment of functional instead of structural alterations (e.g. by flow-243 
mediated dilation), might lead to earlier detection of increased vascular risk related to atopic 244 
sensitization. Furthermore, our study does not allow establishing causality, due to its cross-245 
sectional nature. Yet, there was a tendency towards an association of atopic sensitization with 246 
decreased DC and the non-significance of the results might be, at least in part, due to the 247 
relatively small sample size. We performed analysis of total and specific IgE, which are 248 
qualitative markers of the degree of atopic sensitization on the immunological level (38). 249 
Further, based on interview and clinical measurements, our cohort had a relatively thorough 250 
phenotyping with regard to allergy. Further detail about the number and severity of clinical 251 
episodes of allergic disease, earlier medical treatment and assessment of further inflammatory 252 
markers (i. e. oxLDL, high-sensitivity C-reactive protein, soluble interleukin-2 receptor, 253 
eosinophil cationic protein) would have been helpful for a characterization of the lifetime load 254 
of hyperinflammatory activity in our study population. This may be especially relevant, as the 255 
relatively small number of participants with symptomatic allergic disease might be a major 256 
limiting factor for the non-significance of our results. Future studies should aim towards a 257 
detailed characterization of the extent and severity of inflammatory activity in their 258 
participants, as well as a larger sample size. A selection bias due to the exclusion of the 21 259 
participants, due to denied parental consent for blood tests, seems also very unlikely, as their 260 
empirical, vascular and clinical allergy characteristics were not different from those included 261 
in the study.  262 




To the best of our knowledge, this study is the first to analyze a possible association of atopic 264 
sensitization and allergic diseases with DC and cIMT in adolescents. Whereas evidence points 265 
towards an impact of systemic hyper-inflammation due to atopic sensitization on the vascular 266 
endothelium, our results do not support this assumption in adolescents (2, 3, 9, 15, 20, 39). 267 
Better knowledge about the impact of the clinical character, main determinants and potential 268 
role of disease control of either atopic sensitization or allergic diseases might be valuable. 269 
Further studies should investigate, whether the number and severity of repeated acute clinical 270 
bouts of allergic diseases might be a predictor of early vascular ageing, rather than chronic 271 
low-grade inflammatory activity mediated by atopic sensitization. 272 
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